European results of neutron therapy in soft tissue sarcomas.
The purpose of this publication is to review the data of European neutron therapy facilities in the treatment of soft tissue sarcoma. In the past locally advanced soft tissue sarcoma was a common indication for neutron therapy in several European centers. Data from 1171 patients treated at 11 centers were analysed on the basis of published data or personal communication. Neutron therapy was of benefit especially for patients with primary radiotherapy of inoperable tumors, and with macroscopic disease after surgery. Local control was about 50% in these patients. These results are superior to those from photon therapy from the literature. Results for postoperative neutron therapy after R0- and R1-resection are similar to those from photon therapy. The incidence of late side effects was considerably high in some neutron series. This is influenced by the treatment of most patients with first-generation machines of limited technical standard, and that in most cases large treatment volumes were irradiated.
Schwarz
R
R
Abteilung für Strahlentherapie und Radioonkologie, Universitätskrankenhaus Hamburg-Eppendorf, Germany.
Krüll
A
A
Lessel
A
A
Engenhart-Cabillic
R
R
Favre
A
A
Prott
F J
FJ
Auberger
T
T
Schmidt
R
R
D006801:Humans; D009502:Neutrons / Q000627:therapeutic use*; D012509:Sarcoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D015996:Survival Rate